# Stimulant Withdrawal in Switzerland: Assessment of Mood, Sleep, and Support Needs Canonical: https://rehabswitzerland.com/detox/stimulant-withdrawal/ Publication: Rehab Switzerland Updated: 2026-10-17 Stimulant withdrawal care in Switzerland should assess mood, sleep, physical health, other substance use, and the support needed to remain safe and engaged in treatment. Cocaine, amphetamines, methamphetamine, and prescribed stimulants do not create identical situations. The plan should follow the person's actual exposure and symptoms rather than a standard number of detox days. If there is chest pain, a seizure, serious breathing difficulty, collapse, severe confusion, or immediate danger from suicidal thoughts, [call 144 in Switzerland](https://www.ch.ch/en/safety-and-justice/emergencies-and-danger/). An appointment with an addiction service should not delay care for an acute medical or psychiatric emergency. ## Start by describing the pattern of use Tell the clinician which stimulant was used, how it was taken, the pattern over recent days and weeks, and when it was last used. Explain periods of prolonged wakefulness, repeated use, or a sudden change in the usual pattern. Identify information that is uncertain rather than guessing with confidence. Include prescribed medication, alcohol, cannabis, sedatives, opioids, and other substances. A period described as a stimulant crash may also involve another withdrawal syndrome or a medical problem. The clinician needs the full history before deciding what can be managed at home. Our [cocaine care guide](https://rehabswitzerland.com/conditions/cocaine-use-problems/) and [methamphetamine care guide](https://rehabswitzerland.com/conditions/methamphetamine-use-problems/) address the broader treatment questions. This page focuses on the early period after reducing or stopping and how to organize appropriate clinical follow-up. ## Expect the assessment to look beyond tiredness [Swiss addiction medicine guidance on cocaine withdrawal](https://www.praxis-suchtmedizin.ch/index.php/de/kokain/entzugsbehandlung) describes a changing course that can include exhaustion, depressed mood, sleep disturbance, and craving. Symptoms and their duration vary. A person's experience should not be dismissed because it differs from a simple online timeline. Explain what you can currently manage: eating, drinking, attending appointments, caring for yourself, and staying safe. Tell the team if you cannot carry out basic responsibilities or if the home environment makes continued care difficult. These details help determine the amount of support needed. Do not assume that sleeping for a long period resolves every concern. Ask when reassessment is planned and which changes require earlier contact. A period of apparent physical rest can coexist with significant distress or difficulty thinking clearly. ## Take low mood and suicidal thoughts seriously The [ASAM and AAAP clinical guideline](https://pmc.ncbi.nlm.nih.gov/articles/PMC11105801/) advises monitoring psychiatric symptoms during waning intoxication and withdrawal, including suicide risk. Tell the clinician directly about hopelessness, thoughts of self-harm, or a sense that you cannot remain safe. If there is immediate danger, use emergency care. If the risk is not immediate but distress is increasing, contact the treating service promptly rather than waiting for the end of an assumed withdrawal period. Ask for a specific plan covering the hours when the usual clinician is unavailable. A relative can help communicate observations when the patient agrees, but should not become the sole safeguard for a serious crisis. The clinical team needs to decide whether the current setting and level of support are sufficient. ## Report paranoia, hallucinations, or marked behavioral change [SA Health's amphetamine withdrawal guidance](https://www.sahealth.sa.gov.au/wps/wcm/connect/public%2Bcontent/sa%2Bhealth%2Binternet/clinical%2Bresources/clinical%2Bprograms%2Band%2Bpractice%2Bguidelines/substance%2Bmisuse%2Band%2Bdependence/substance%2Bwithdrawal%2Bmanagement/amphetamine%2Bwithdrawal%2Bmanagement) notes that psychotic symptoms may occur and that significant symptoms can require inpatient mental-health care. This supports prompt assessment rather than assuming that unusual beliefs or perceptions will settle without help. Describe what the person is experiencing and when it began. The clinician may need to consider intoxication, withdrawal, sleep disruption, an underlying psychiatric condition, or another cause. Avoid trying to settle the diagnosis through an argument about whether an experience is real. If you are helping someone, explain the behavior and safety concerns to the service. Do not attempt to physically manage an unsafe situation alone. A calm setting may be helpful while professional assistance is arranged, but it does not replace assessment. ## Review physical symptoms separately [Infodrog describes important physical risks associated with methamphetamine](https://www.infodrog.ch/de/wissen/suchtformen/methamphetamin.html), including overheating and cardiovascular complications. New chest pain, collapse, severe breathing problems, or other concerning symptoms should not automatically be labeled withdrawal or anxiety. Tell the team about existing heart conditions, injuries, weight changes, dental problems, and any possible infection exposure. Explain the route of use because it may change which assessments are relevant. Ask what needs attention now and what can be arranged through continuing care. For a person whose main concern is exhaustion, a physical review can still be useful. The goal is to understand the situation, not to order every possible test. The clinician should explain which findings would alter the plan. ## Make a realistic sleep plan The ASAM and AAAP guideline recognizes that increased sleep early in withdrawal can be followed by persistent sleep problems. It recommends assessing and treating continuing symptoms rather than expecting a single fixed pattern. Tell the clinician how sleep changes across the day and night. Discuss ordinary routines that affect the plan: shift work, caring for children, shared accommodation, and the temptation to use a stimulant to meet commitments. A schedule that assumes uninterrupted rest may not be realistic without practical support. Do not add borrowed sleeping tablets, alcohol, or unreviewed sedating products to force sleep. If medication is prescribed, ask why it is being used, how long it is intended to continue, and who will review it. The next clinician should receive those instructions. ## Distinguish persistent symptoms from a separate condition Depression, anxiety, insomnia, and other symptoms can continue beyond the initial withdrawal phase. The ASAM and AAAP guideline recommends ongoing assessment of these difficulties. Their persistence should prompt review rather than a conclusion that recovery has failed. Explain whether similar symptoms occurred before stimulant use or during earlier periods without it. Bring previous diagnoses and treatment records where available. The clinician can use the timing and wider history to decide what needs treatment now and what needs further observation. Do not postpone all mental-health care until an arbitrary abstinence deadline. Equally, avoid treating every early symptom as a permanent diagnosis. Ask how the team will revisit its working explanation as the clinical picture becomes clearer. ## Coordinate prescribed stimulants with the existing prescriber If the medicine was prescribed for ADHD or another condition, contact the prescriber before making changes. Explain whether it has been taken as directed, used more often, obtained from additional sources, or combined with other substances. Those are different clinical circumstances and should be discussed explicitly. Ask how the underlying condition will be managed if a change is appropriate. Concerns about misuse should not erase a legitimate diagnosis, and a prescription should not prevent the clinician from assessing harmful use. A coordinated review can address both questions. Our [prescription stimulant guide](https://rehabswitzerland.com/conditions/prescription-stimulant-misuse/) explains this distinction. Bring the medication packaging or accurate prescription details so that the receiving service does not have to infer the formulation from an informal name. ## Choose an ongoing treatment approach The [NHS describes psychological treatment for cocaine problems](https://www.nhs.uk/live-well/addiction-support/cocaine-get-help/), including cognitive behavioral therapy and structured incentives. The ASAM and AAAP guideline identifies contingency management as a key evidence-based component of stimulant treatment. Ask the Swiss service which approaches it actually provides. Contingency management uses agreed incentives linked to treatment goals. It is different from a family improvising rewards or threats. If the service offers it, ask how goals, monitoring, and incentives are organized and how it fits with other therapy. Our [CBT guide](https://rehabswitzerland.com/treatment/cognitive-behavioral-therapy/) explains how sessions can connect situations, thoughts, feelings, and actions. The useful question is how the treatment will address the person's recurring pattern, not simply whether the therapy name appears in a brochure. ## Consider a Swiss outpatient pathway when appropriate [Integrierte Suchthilfe Winterthur](https://ipw.ch/angebot/erwachsene/integrierte-suchthilfe-winterthur) provides an integrated regional addiction service. Its approach can be relevant to assessment and continuing support for cocaine and other substance concerns. Confirm the appropriate entry point, catchment, referral requirements, and availability directly. Outpatient care can allow treatment to address everyday triggers as they occur, but it must fit current clinical and practical needs. If the person cannot remain safe, has severe psychiatric symptoms, or needs a higher level of medical support, the clinician should arrange an appropriate alternative. Our [Swiss outpatient treatment guide](https://rehabswitzerland.com/rehab/outpatient-rehab/) helps compare appointment frequency, coordination, and support between sessions. Residential care is a possible setting, not an automatic requirement for every stimulant concern. ## Plan the first difficult situation after withdrawal Choose a likely situation with the therapist: an evening associated with use, a demanding workday, a social invitation, or a period of loneliness. Discuss what usually happens before use and what response is realistically available. A specific example makes the plan easier to practice. Arrange the next appointment and agree on how to report renewed use without abandoning treatment. Tell the team if cravings, mood, or sleep are worsening. Follow-up should be able to respond to the actual course rather than depending on the person appearing symptom-free. If concentration is poor, ask for a short written plan with the next appointment, current medication instructions, and contact details. Choose a manageable first task rather than leaving with a long list of changes. Discuss with the clinician when work, driving, or other demanding activities can be resumed safely in your particular circumstances. The early withdrawal period is one part of stimulant care. Its practical endpoint is a stable enough situation to continue treatment, with a clear route for urgent concerns and a plan that addresses the patterns likely to return in ordinary life.